How to Read Johnson & Johnson's Quarterly Filing
The 10-Q is the standard quarterly report filed by US public companies with the Securities and Exchange Commission (SEC). Unlike the annual 10-K, the 10-Q contains unaudited financial statements — but they are still legally required to be accurate and complete under SEC rules (Section 13 or 15(d) of the Securities Exchange Act of 1934).
For Johnson & Johnson (JNJ), each 10-Q typically contains:
| Section | What It Reveals |
|---------|----------------|
| Part I, Item 1 | Financial Statements (Income, Balance Sheet, Cash Flow) |
| Part I, Item 2 | Management Discussion & Analysis (MD&A) — the most insightful section |
| Part I, Item 3 | Quantitative and Qualitative Disclosures About Market Risk |
| Part I, Item 4 | Controls and Procedures |
| Part II, Item 1 | Legal Proceedings |
| Part II, Item 1A | Risk Factors (updates only — full list is in the 10-K) |
| Part II, Item 6 | Exhibits and certifications signed by the CEO and CFO |
Key Metrics to Track in JNJ's Results
When evaluating Johnson & Johnson's quarterly performance, experienced investors focus on these core metrics:
-
Revenue (Top Line) — Total sales before any deductions. Year-over-year revenue growth is the primary indicator of business momentum for JNJ.
-
Gross Margin — Revenue minus cost of goods sold, expressed as a percentage. A rising gross margin suggests Johnson & Johnson has pricing power or improving input costs.
-
Operating Income — Profit from core business operations, excluding interest and taxes. This isolates JNJ's business fundamentals from financial engineering.
-
Net Income (Bottom Line) — The "final number" — total profit after all expenses, taxes, and non-operating items. However, be cautious of one-time gains or charges that distort this figure.
-
Diluted EPS — Earnings divided by the fully diluted share count. This is what analysts report on when they say "JNJ beat/missed estimates."
-
Free Cash Flow — Operating cash flow minus capital expenditures. A company can report positive net income but negative free cash flow — a serious red flag.
-
Revenue Guidance — Forward-looking statements from management about expected performance. This often moves JNJ's stock price more than the actual quarter's results.
Analyze Johnson & Johnson's Quarterly Results with AI
Instead of manually parsing a 50-100 page 10-Q, use MoneySense AI's Filing Analysis Tool to get instant insights:
- Instant Summary — Get a TL;DR of JNJ's quarterly performance in 30 seconds
- Metric Extraction — Revenue, net income, EPS, margins automatically pulled and compared to prior quarters
- Sentiment Analysis — Detect if management's language has shifted toward optimism or caution
- Risk Detection — New risk factors, legal proceedings, or material uncertainties are highlighted
- Chat Interface — Ask follow-up questions: "What happened to Johnson & Johnson's gross margin?" or "Any new debt issuance?"
Data Accuracy & Methodology
Data sourced from official regulatory databases. This page is maintained by the MoneySense AI editorial team and updated regularly. Our AI analysis is powered by state-of-the-art language models fine-tuned for financial document comprehension. Every AI insight includes citations so you can verify against the original source filing. MoneySense AI is not a financial advisor — always do your own due diligence.
Last reviewed: 2026-03-04
